{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-069162","form_type":"8-K","ticker":"OBIO","cik":"0001814114","company_name":"Orchestra BioMed Holdings, Inc.","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.779892+00:00","generated_at":"2026-06-14T05:11:21.121309+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Orchestra BioMed reports positive clinical data; plans pivotal trials H2 2023","bullets":["BackBeat CNT showed 8.1 mmHg net reduction in 24-hour aSBP at 6 months and 17.5 mmHg oSBP reduction at 2 years.","Virtue SAB in coronary ISR: 0.12 mm late lumen loss at 6 months, 2.8% target lesion failure at 1 year.","Pivotal trials for BackBeat CNT and Virtue SAB intend to start in H2 2023.","Medtronic collaboration: double-digit revenue share and $50M equity investment; Terumo: 10-15% royalty and $30M upfront.","Target markets: >$10B (BackBeat CNT) and >$3B (Virtue SAB); strong balance sheet with committed investors."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-069162","json":"https://secwatch.observer/filing/0001104659-23-069162.json","markdown":"https://secwatch.observer/filing/0001104659-23-069162.md","text":"https://secwatch.observer/filing/0001104659-23-069162.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923069162/0001104659-23-069162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923069162/tm2318000d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T05:11:21.121309+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}